首页> 外文期刊>Pferdeheilkunde >Embryo recovery rate following superovulation with equine pituitary extract (eFSHReg.) in mares. (20. Arbeitstagung DVG-Fachgruppe 'Pferdekrankheiten'.)
【24h】

Embryo recovery rate following superovulation with equine pituitary extract (eFSHReg.) in mares. (20. Arbeitstagung DVG-Fachgruppe 'Pferdekrankheiten'.)

机译:在马中垂体提取物(eFSHReg。)超排卵后的胚胎恢复率。 (第20届DVG专家组“马病”工作会议。)

获取原文
获取原文并翻译 | 示例
           

摘要

Embryo recovery from single ovulating mares is approximately 50% per estrous cycle, leading to a non-economical state of embryo transfer in the mare. An ability to consistently induce multiple follicles and ovulations in estrous cycling mares would enhance embryo recovery from donor mares, provide multiple follicles for collection of oocytes, and improve pregnancy rates from subfertile mares. There have been numerous approaches to superovulation of the mare. Injections of porcine FSH, inhibin vaccines, equine chorionic gonadotropin (eCG) and GnRH have been of limited success in stimulating multiple ovulations in the mare. Numerous studies have shown that injection of equine pituitary extract (EPE) will result in three to four ovulations per estrous cycle and two embryos. Recently, a commercial purified equine pituitary extract product (eFSHReg.) has been available. In the present study six normally cycling mares were investigated over five cycles and ovulation rate and embryo recovery rate were compared between control cycles and stimulated cycles. Cycle one and three were designed as control cycles without stimulation and insemination. In cycles 2 and 4 mares were treated with 12.5 mg eFSHReg. intramuscularly twice daily beginning when the diameter of the largest follicle was 20 to 25 mm. Prostaglandin was administered on the second day of eFSHReg. therapy. Treatment with eFSHReg. was continued until follicle(s) were 32-35 mm in diameter. The mares were subsequently allowed to 'coast' for 36 h, after which 2500 IU human chorionic gonadotropin were administered to induce ovulation. Mares were inseminated with 750 Mio. progressive motile sperms of a fertile warmblood stallion. Embryo recovery was performed 6.5 days following ovulation. In the last cycle (5) mares were treated and inseminated in the same way than in cycle 2 and 4, but without eFSHReg. stimulation. Ovulation rate in control cycles was lower (1.3 ovulations) than in eFSHReg. treated cycles (4.4 ovulations). The number of days of eFSHReg. treatment required for reaching a follicle size of 32-35 mm was on average 4,0 days. Embryo recovery rate in control mares was 1.2 per cycle, whereas in eFSHReg. treated mares 0 2.9 embryos could be flushed. The eFSHReg. protocol used in this study was efficient to induce multiple ovulations and increase embryo recovery rate in mares. Nevertheless the number of embryos obtained is quite encouraging, individual mare variation is considerable. Being able to identify donor mares that respond favorably to eFSH based on follicular development, ovulation and embryo recovery would be a great advantage. In current studies a possible influence of follicle development and genital blood flow on embryo recovery rate is investigated to identify "good donor mares" in a superovulation program.
机译:每个发情周期从单个排卵母马中回收的胚芽约为50%,这导致母猪中胚胎转移的非经济状态。在发情的循环母马中持续诱导多个卵泡和排卵的能力将增强供体母猪的胚胎恢复能力,为卵母细胞的收集提供多个卵泡,并提高不育母马的妊娠率。母马超排卵的方法很多。注射猪FSH,抑制素疫苗,马绒毛膜促性腺激素(eCG)和GnRH在刺激母猪多次排卵方面取得的成功有限。大量研究表明,注射马垂体提取物(EPE)将导致每个动情周期排卵3至4次,并产生两个胚胎。最近,已经有商业纯化的马垂体提取物产品(eFSHReg。)。在本研究中,对六个正常周期的母马进行了五个周期的研究,比较了控制周期和刺激周期之间的排卵率和胚胎恢复率。将第一和第三周期设计为无刺激和授精的对照周期。在第2和第4周期中,母马用12.5 mg eFSHReg处理。当最大卵泡的直径为20至25 mm时,每天两次肌内注射。在eFSHReg的第二天服用前列腺素。治疗。用eFSHReg处理。持续进行直到卵泡直径为32-35mm。随后让母马“ ast翔” 36小时,然后给予2500 IU人绒毛膜促性腺激素诱导排卵。母马受精于750Mio。繁殖的温血种马的进行性运动精子。排卵后6.5天进行胚胎恢复。在最后一个周期(5)中,对母马的处理和授精的方式与周期2和4中相同,但没有eFSHReg。刺激。控制周期的排卵率比eFSHReg低(1.3排卵)。治疗周期(排卵4.4次)。 eFSHReg的天数。卵泡大小达到32-35 mm所需的平均治疗时间为4.0天。对照母马的胚胎回收率是每个周期1.2,而eFSHReg中。处理过的母马0 2.9胚胎可被冲洗。 eFSHReg。在这项研究中使用的协议是有效的诱导多个排卵,并提高母马的胚胎恢复率。尽管如此,获得的胚胎数量还是令人鼓舞的,个体母马的变异也很大。能够基于卵泡发育,排卵和胚胎恢复识别出对eFSH有良好反应的供体母马将是一个巨大的优势。在当前的研究中,研究了卵泡发育和生殖器血流对胚胎恢复率的可能影响,以鉴定超排卵程序中的“良好供体母马”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号